Abstract:Previously, we have successfully constructed replication-competent hepatitis B virus (HBV) vectors by uncoupling the P open reading frame (ORF) from the preC/C ORF to carefully design the transgene insertion site to overcome the compact organization of the HBV genome and maintain HBV replication competence. Consequently, the replication-competent HBV vectors carrying foreign genes, including pCH-BsdR, carrying blasticidin resistance gene (399 bp), and pCH-hrGFP, carrying humanized renilla green fluorescent protein gene (720 bp), were successfully obtained. However, the replication efficiency of the former is higher but it is tedious to use, while that of the latter is poor and cannot be quantified. Hence, we need to search for a new reporter gene that is convenient and quantifiable for further research.To establish a helpful tool for intracellular HBV replication and anti-viral drugs screening studies.We utilized the replication-competent HBV viral vectors constructed by our laboratory, combined with the secreted luciferase reporter gene, to construct replication-competent HBV vectors expressing the reporter gene secretory Nanoluc Luciferase (SecNluc). HepG2.TA2-7 cells were transfected with this vector to obtain cell lines with stably secreted HBV particles carrying secNluc reporter gene.The replication-competent HBV vector carrying the SecNluc reporter gene pCH-sNLuc could produce all major viral RNAs and a full set of envelope proteins and achieve high-level secreted luciferase expression. HBV replication intermediates could be produced from this vector. Via transfection with pTRE-sNLuc and selection by hygromycin, we obtained isolated cell clones, named HBV-NLuc-35 cells, which could secrete secNLuc recombinant viruses, and were sensitive to existing anti-HBV drugs. Using differentiated HepaRG cells, it was verified that recombinant HBV possessed infectivity.Our research demonstrated that a replication-competent HBV vector carrying a secreted luciferase transgene possesses replication and expression ability, and the established HBV replication and expression cell lines could stably secrete viral particles carrying secNluc reporter gene. More importantly, the cell line and the secreted recombinant viral particles could be used to trace HBV replication or infection.

[Development and Identification of the Recombinant Lentivirus Co-expressing HCV Structural Protein and Secreted Gaussia Luciferase (Gluc)].

[Construction of an Expression Vector with a Bicistron of Green Fluorescent Protein and HCV 5'NCR Controlled Luciferase Gene and Its Expression in Hepatocytes].

A Novel Luciferase and GFP Dual Reporter Virus for Rapid and Convenient Evaluation of Hepatitis C Virus Replication.

Construction of an Effective Eukaryotic Bi-Cistronic Expression Vector Containg HCV Internal Ribosome Entry Site

Characterization of the Single Cycle Replication of HIV-1 Expressing Gaussia Luciferase in Human PBMCs, Macrophages, and in CD4(+) T Cell-Grafted Nude Mouse.

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Design and construction of HCV NS5B eukaryotic expression vector with Tet-on and Cre/loxP system

Expression of Structural Proteins of Hepatitis C Virus (HCV) in Mammalian Cells

Expression and Characterization of Hepatitis C Virus E2 Glycoprotein Fused to Hepatitis B Virus Pres1(21-47) Fragment in CHO Cells

Co-Expression of Hepatitis B Virus Proteins and Green Fluorescent Protein After Eukaryotic Cell in vitro and Hydrodynamics-Based in vivo Transfection

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector

Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines

Retroviral Vector Mediated HCV E1E2 Envelope Protein Expression in Eukaryotic Cells and Animal Immune Experiment

[Construction of Eukaryotic Expression Vector Expressing Hepatitis B Virus HBsAg and EGFP Fusion Protein and Establishment of Stable Transfected Chang Liver Cell Line].

[Expression of Hepatitis C Virus Envelope Proteins with a Recombinant Baculovirus Expression System].

Establishment of a Controllable Cell Model with Fusion Gene of Hepatitis C Virus Cdna and Luciferase Reporter Gene

Construction and Gene Immunization of Recombinant Expression Plasmid of Hepatitis C Virus Core Gene

Construction and Expression of Eukaryotic Expression Plasmid of Core Gene of Hepatitis C Virus

Construction and Identification of Lentiviral Expression Vector Carry CEA Gene

Expression, Identification and Characterization of HCV2a(JFH1) NS5A Protein in E.coli and HEK 293T Cells

In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter.